Mid-term outcomes of the COMMENCE trial investigating mitral valve replacement using a bioprosthesis with a novel tissueCentral MessagePerspective

Mid-term outcomes of the COMMENCE trial investigating mitral valve replacement using a bioprosthesis with a novel tissueCentral MessagePerspective

Objective: Novel tissue leaflets (RESILIA tissue) may improve durability of bioprosthetic heart valves. The COMMENCE trial is an ongoing prospective study to evaluate valve replacement using RESILIA tissue. This report describes mid-term outcomes in the mitral cohort of COMMENCE. Methods: Adult pati...

Full description

Bibliographic Details
Main Authors: David A. Heimansohn, MD, Craig Baker, MD, Evelio Rodriguez, MD, Hiroo Takayama, MD, PhD, Francois Dagenais, MD, David S. Talton, MD, Mubashir A. Mumtaz, MD, Philippe Pibarot, DMV, PhD, John D. Puskas, MD
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:JTCVS Open
Subjects:
mitral valve replacement
mitral valve diseases
bioprosthetic valve
RESILIA tissue
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273623001225

Internet

http://www.sciencedirect.com/science/article/pii/S2666273623001225

Similar Items